Denver Arthritis Center offers referred infusion care for new patients | Learn More
Living with osteoporosis means worrying about fractures from everyday activities that most people take for granted. You might be afraid to lift your grandchildren, hesitate to go for walks on uneven ground, or live in constant fear that a simple fall could result in a broken hip or spine fracture. Perhaps you've already experienced a fracture and learned you have osteoporosis, or maybe a bone density test revealed concerning results about your bone health.
The silent nature of osteoporosis makes it particularly frightening; your bones can weaken for years without any symptoms until a fracture occurs. Understanding that osteoporosis is a progressive disease where bones lose density and become fragile is the first step. The encouraging news is that with proper diagnosis and treatment, you can strengthen your bones, reduce your fracture risk, and maintain your independence and active lifestyle.
Denver Arthritis Clinic has been at the forefront of osteoporosis treatment since 1976, helping patients throughout the Denver metro area protect their bone health and prevent fractures. Our board-certified rheumatologists are among the best osteoporosis doctors in Colorado, with extensive experience diagnosing bone density problems and developing comprehensive treatment plans tailored to each patient's unique situation.
We offer the full spectrum of osteoporosis medications, from oral bisphosphonates to advanced infusion therapies like Reclast, Prolia, and Evenity administered at our state-of-the-art infusion centers in Lowry and Lone Tree . Our bone density specialists understand that effective osteoporosis treatment requires more than just prescribing medication; it involves evaluating your fracture risk, identifying factors that may be affecting your bone health, and creating a personalized plan that fits your lifestyle.
Don't wait for a fracture to take osteoporosis seriously. Schedule an appointment with Denver Arthritis Clinic to meet with an osteoporosis specialist who will assess your bone health, discuss your risk factors, and recommend the best treatment for osteoporosis based on your individual needs.
Osteoporosis is a progressive bone disease characterized by decreased bone density and deterioration of bone tissue, leading to increased bone fragility and susceptibility to fractures. The name literally means "porous bones," and it accurately describes what happens as the condition develops. Your bones are living tissue that constantly breaks down and rebuilds. In healthy bones, this process stays balanced. With osteoporosis, bone breakdown outpaces bone formation, causing bones to become weak and brittle. Understanding how osteoporosis develops, recognizing your risk factors, and knowing about available treatment options empowers you to take control of your bone health.
The concerning aspect of osteoporosis is that it's often called a "silent disease" because bone loss occurs gradually without obvious symptoms. Many people don't realize they have osteoporosis until they suffer a fracture. However, there can be warning signs as the condition progresses. Loss of height over time, developing a stooped or hunched posture (sometimes called dowager's hump), back pain caused by fractured or collapsed vertebrae, and bones that break more easily than expected are all potential indicators.
Osteoporosis is diagnosed primarily through bone density testing, specifically a DEXA (dual-energy X-ray absorptiometry) scan. This painless, non-invasive test measures bone mineral density in your spine, hip, and sometimes forearm. The results are reported as T-scores. A T-score of -1.0 or above is considered normal bone density. A T-score between -1.0 and -2.5 indicates osteopenia (low bone mass that's not severe enough to be called osteoporosis). A T-score of -2.5 or lower indicates osteoporosis.
The National Osteoporosis Foundation recommends bone density testing for women age 65 and older, men age 70 and older, postmenopausal women under 65 with risk factors, men ages 50-69 with risk factors, anyone who has broken a bone after age 50, anyone taking medications that can cause bone loss, and anyone with conditions associated with bone loss. Your doctor may also recommend testing if you've lost height or developed a curved spine.
Understanding your risk factors for osteoporosis is important because many can be modified to improve your bone health. Non-modifiable risk factors include age (bone density naturally decreases as you age, with rapid bone loss occurring in the years following menopause for women), gender (women are at higher risk than men, though men can certainly develop osteoporosis), body size (small, thin-boned individuals are at greater risk), ethnicity (white and Asian women are at highest risk, though osteoporosis affects all ethnic groups), and family history (having a parent or sibling with osteoporosis increases your risk).
Modifiable risk factors that you can address include hormone levels. Low estrogen levels in women (from menopause, surgical removal of ovaries, or excessive exercise that stops menstruation) and low testosterone levels in men increase osteoporosis risk. Dietary factors matter significantly; low calcium intake throughout life contributes to decreased bone density, early bone loss, and increased fracture risk. Vitamin D deficiency prevents calcium absorption, leading to bone loss.
Lifestyle choices significantly impact bone health. A sedentary lifestyle means bones aren't stimulated to maintain their strength. Excessive alcohol consumption interferes with calcium absorption and bone formation. Tobacco use contributes to weak bones and may interfere with estrogen's protective effects on bones. Certain medications can cause bone loss if used long-term, including corticosteroids like prednisone, some anti-seizure medications, proton pump inhibitors for acid reflux, and certain cancer treatments.
Medical conditions associated with increased osteoporosis risk include celiac disease, inflammatory bowel disease, kidney or liver disease, rheumatoid arthritis and other inflammatory conditions, hyperthyroidism or hyperparathyroidism, and eating disorders like anorexia nervosa. Identifying and addressing these risk factors is an important part of osteoporosis prevention and treatment.
At Denver Arthritis Clinic, we offer a comprehensive range of medications to treat osteoporosis, each working through different mechanisms to protect and strengthen your bones. The choice of medication depends on your bone density scores, fracture risk, other health conditions, and personal preferences.
Bisphosphonates are the most commonly prescribed osteoporosis medications. They work by slowing or stopping bone breakdown, allowing bone-building cells to work more effectively. Oral bisphosphonates like alendronate and risedronate are taken daily or weekly. Zoledronic acid (Reclast) is given as an annual infusion and is highly effective for preventing spine and hip fractures. The convenience of yearly dosing makes Reclast an attractive option for many patients. Ibandronate (Boniva) can be given as a quarterly infusion for patients who prefer less frequent dosing than daily pills but more frequent than annual infusions.
Denosumab (Prolia) is a biologic medication given as an injection every six months. It works differently than bisphosphonates by blocking RANK ligand, a protein essential for the formation, function, and survival of osteoclasts (cells that break down bone). Prolia significantly reduces fracture risk in the spine, hip, and other bones. Many patients appreciate the convenience of twice-yearly injections.
Hormone-related therapies include teriparatide and abaloparatide, which are parathyroid hormone-related medications. Unlike other osteoporosis drugs that primarily prevent bone loss, these medications actually stimulate new bone formation. They're given as daily self-injections and are typically reserved for people with severe osteoporosis or those who haven't responded to other treatments. Treatment is usually limited to two years due to potential side effects.
Evenity (romosozumab) represents a newer class of osteoporosis treatment. This medication has a dual effect: it stimulates bone formation while reducing bone breakdown. Given as monthly injections for one year, Evenity is typically reserved for postmenopausal women with very high fracture risk. Clinical trials showed it significantly reduces spine fractures and, to a lesser extent, hip fractures.
For many patients, infusion therapy offers significant advantages over daily or weekly oral medications. Infusions eliminate concerns about remembering to take pills, ensure complete medication delivery without GI upset that sometimes occurs with oral bisphosphonates, and provide convenient dosing schedules ranging from quarterly to annually.
When you receive osteoporosis infusion therapy at Denver Arthritis Clinic, you'll be treated at our comfortable outpatient infusion centers in Lowry or Lone Tree. The process is straightforward. Reclast infusions take about 15 minutes, though you'll be monitored for a period afterward. Most patients experience minimal side effects, though some develop temporary flu-like symptoms within the first few days after the infusion. These typically resolve quickly.
Before starting any osteoporosis medication, your doctor will ensure your calcium and vitamin D levels are adequate and check your kidney function. You'll continue taking calcium and vitamin D supplements as recommended throughout your treatment. Regular follow-up, including periodic bone density scans, helps your doctor monitor your response to treatment and adjust your plan as needed.
This is an important question, and the answer depends on your bone density test results and overall fracture risk. Calcium and vitamin D supplements alone are generally not sufficient to treat established osteoporosis, though they're important supporting measures. You should consider osteoporosis medication if you have a T-score of -2.5 or lower (meeting the definition of osteoporosis), you have osteopenia (T-score between -1.0 and -2.5) plus other risk factors for fracture, you've already had a fracture from minimal trauma, or you're taking medications like corticosteroids that cause bone loss.
Your doctor will assess your 10-year fracture risk using tools like the FRAX calculator, which considers your bone density, age, and other risk factors. If your risk exceeds certain thresholds (generally 3% or higher for hip fracture or 20% or higher for major osteoporotic fracture), medication is typically recommended even if you don't yet have osteoporosis by strict T-score criteria.
Calcium and vitamin D are essential for bone health and should be part of every osteoporosis treatment plan, but they work alongside medication rather than replacing it. Most adults need 1,000-1,200 mg of calcium daily (from diet plus supplements if needed) and 800-1,000 IU of vitamin D daily. Your doctor will help you determine the right combination of lifestyle measures, supplements, and medication for your situation.
Osteopenia and osteoporosis represent different degrees of bone loss. Osteopenia is lower bone density than normal for your age, but not low enough to be classified as osteoporosis. It's essentially a middle ground between healthy bones and osteoporosis. Your T-score with osteopenia falls between -1.0 and -2.5. Osteoporosis is more severe bone loss, with a T-score of -2.5 or lower, indicating significantly increased fracture risk.
Not everyone with osteopenia needs medication. The decision depends on your overall fracture risk, which takes into account factors beyond just your bone density. You might benefit from medication for osteopenia if you're a postmenopausal woman with other significant risk factors, you've had a fracture from minimal trauma (like falling from standing height), you're taking corticosteroids or other medications that cause bone loss, you have a medical condition that increases fracture risk, or your FRAX score indicates high fracture risk despite "only" having osteopenia.
For many people with osteopenia, lifestyle modifications may be sufficient. This includes ensuring adequate calcium and vitamin D intake, engaging in regular weight-bearing and strength-training exercise, avoiding smoking and excessive alcohol, and addressing any underlying medical conditions affecting bone health. Regular monitoring with repeat bone density scans helps track whether your bones are stable or continuing to lose density, which influences treatment decisions.
The duration of osteoporosis treatment varies by individual and by medication. For bisphosphonates like Reclast or oral alendronate, many experts recommend a "drug holiday" after 3-5 years of treatment for patients at moderate fracture risk, especially if bone density has improved and remains stable. These medications remain in bones for years after you stop taking them, continuing to provide some protection. However, patients at very high fracture risk (such as those who have had fractures while on treatment or those with very low bone density) may need to continue treatment longer.
Denosumab (Prolia) works differently and must be approached more carefully. Unlike bisphosphonates, Denosumab's effects wear off quickly when stopped, and there's a risk of rapid bone loss and increased fracture risk when discontinued. If you need to stop Denosumab, your doctor will typically transition you to another medication to prevent rebound bone loss.
Anabolic medications like teriparatide, abaloparatide, and Evenity have time-limited use built into their treatment protocols. Teriparatide and abaloparatide are typically given for 18-24 months, and Evenity for 12 months, followed by transition to an anti-resorptive medication like a bisphosphonate to maintain the gains achieved.
The decision about how long to continue treatment is individualized based on your fracture risk reassessment, bone density trends, whether you've had any fractures, other medical conditions, and tolerance of the medication. Regular follow-up with your osteoporosis specialist ensures your treatment plan evolves appropriately with your changing needs and circumstances.